温嶺工量刃具(01379.HK)耗資5206萬元成功競投浙江温嶺地塊使用權
格隆匯6月10日丨温嶺工量刃具(01379.HK)公吿,於2025年6月10日,温嶺旭日(公司的直接全資附屬公司)與自然資源局訂立成交確認書,確認温嶺旭日成功競投自然資源局於該宗拍賣上出讓位於中國浙江省温嶺市温嶠鎮前洋下村該地塊的土地使用權。由於成功競投,故温嶺旭日與自然資源局於2025年6月10日訂立國有建設用地使用權出讓合同,據此,自然資源局同意出讓,且温嶺旭日同意收購該地塊的土地使用權,總代價為人民幣5206萬元。
該地塊將用作建設位於中國浙江省温嶺市温嶠鎮的温嶺市山海天嶠建設項目。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.